CLOVER HEALTH INVESTMENTS, CORP. /DE — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
This filing consists solely of Sarbanes-Oxley certification exhibits (31.1, 31.2, 32.1, 32.2) signed by CEO Andrew Toy and Interim CFO Clay Thornton on August 7, 2026, for the six-month period ended June 30, 2026. The certifications attest to the accuracy of financial statements and effectiveness of disclosure controls and internal controls over financial reporting. No specific financial data, transactions, guidance changes, or operational developments are disclosed in these exhibits.
Why this rating
Routine SOX certification boilerplate; no substantive business event, transaction, or material change disclosed. Administrative compliance filing.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.